Jorge L. Braier

B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

Journal: Blood advances
Published: February 11, 2026

Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell Histiocytosis.

Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell Histiocytosis.

Journal: Blood advances
Published: February 11, 2026

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Journal: Blood advances
Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances
Published: October 03, 2025

Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology.

Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology.

Journal: Science immunology
Published: December 16, 2022

Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib.

Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib.

Journal: Pediatric dermatology
Published: December 22, 2021

Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.

Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.

Journal: Hormone research in paediatrics
Published: February 16, 2021

Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.

Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.

Journal: The Journal of pediatrics
Published: February 08, 2021

High prevalence of BRAFV600E in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis.

High prevalence of BRAFV600E in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis.

Journal: Pediatric blood & cancer
Published: August 06, 2020

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Journal: Blood
Published: March 15, 2018

Is Langerhans cell histiocytosis a neoplasia?

Is Langerhans cell histiocytosis a neoplasia?

Journal: Pediatric blood & cancer
Published: August 21, 2016

Predictor Variables of Developing Anterior Pituitary Deficiencies in a Group of Paediatric Patients with Central Diabetes Insipidus and Langerhans Cell Histiocytosis.

Predictor Variables of Developing Anterior Pituitary Deficiencies in a Group of Paediatric Patients with Central Diabetes Insipidus and Langerhans Cell Histiocytosis.

Journal: Hormone research in paediatrics
Published: August 16, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026